HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lectin-like oxidized LDL receptor 1 is involved in CRP-mediated complement activation.

AbstractBACKGROUND:
C-reactive protein (CRP) is purported to be a risk factor that acts independently of LDL cholesterol in predicting all-cause mortality in patients with ischemic heart disease. Lectin-like oxidized LDL receptor 1 (LOX-1) impairs endothelial function and exacerbates myocardial injury. We recently demonstrated that CRP increased vascular permeability through direct binding to LOX-1. Here we examined, using a hypertensive rat model, whether LOX-1 is involved in CRP-induced complement activation.
METHODS AND RESULTS:
In the cultured LOX-1-expressing cell line hLOX-1-CHO, CRP increased complement activation, but did not do so in native CHO cells. Depleting C1q from serum abolished CRP-induced complement activation. Incubation of CRP with serum on immobilized recombinant LOX-1 similarly showed that CRP activated C1q-requiring classical complement pathway in a LOX-1-dependent manner. Interestingly, the interaction between CRP and LOX-1 was dependent on Ca²⁺ ion and competed with phosphocholine, suggesting that LOX-1 bound to the B-face of CRP with a phosphocholine-binding domain. This was in contrast to Fcγ receptors, to which CRP bound in A-face with complement-binding domain. In vivo, intradermal injection of CRP to hypertensive SHRSP rats induced complement activation detected by C3d deposition and leukocyte infiltration around the injected area. Anti-LOX-1 antibody reduced the extent of complement activation and leukocyte infiltration.
CONCLUSIONS:
LOX-1 appears to be involved in CRP-induced complement activation, and thus may serve to locate the site of CRP-induced complement activation and inflammation.
AuthorsYoshiko Fujita, Saburo Yamaguchi, Akemi Kakino, Shin Iwamoto, Ryo Yoshimoto, Tatsuya Sawamura
JournalClinical chemistry (Clin Chem) Vol. 57 Issue 10 Pg. 1398-405 (Oct 2011) ISSN: 1530-8561 [Electronic] England
PMID21821723 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Immobilized Proteins
  • Recombinant Proteins
  • Scavenger Receptors, Class E
  • Phosphorylcholine
  • Complement C1q
  • Complement C3d
  • C-Reactive Protein
Topics
  • Animals
  • Antibodies (pharmacology)
  • C-Reactive Protein (pharmacology, physiology)
  • CHO Cells
  • Cell-Free System
  • Complement Activation
  • Complement C1q (metabolism)
  • Complement C3d (metabolism)
  • Cricetinae
  • Cricetulus
  • Humans
  • Immobilized Proteins
  • Male
  • Neutrophil Infiltration
  • Phosphorylcholine (pharmacology)
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Recombinant Proteins (pharmacology)
  • Scavenger Receptors, Class E (immunology, physiology)
  • Skin (blood supply, drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: